SFDA CEO explores global best practices in advanced therapies in US

TOKYO: CEO of the Saudi Food and Drug Authority Dr. Hisham S. Aljadhey conducted a series of site visits to specialized medical and research centers in the US last week. The visits aimed to leverage global expertise in the latest technologies, as well as developments within advanced therapies and biotechnology. They took place on the sidelines of Dr. Aljadhey’s participation in the Drug Information Association annual meeting in Philadelphia, Pennsylvania, held from June 14-18.

Raccontata daarabnews.comarabnews.jp